We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on UnitedHealth (UNH – Research Report) and Eli ...

Ore Huiying / Bloomberg / Getty Images Pharmaceutical company Eli Lilly is expected to report ... These include white papers, government data, original reporting, and interviews with industry ...

Eli Lilly (LLY) stock is higher Thursday after the pharmaceutical company beat profit expectations and matched revenue forecasts for its fourth quarter and issued a better-than-expected outlook ...

In a report released today, Geoff Meacham from Citi maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares ...

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth ... primary sources to support their work. These include white papers, government data, original reporting, and ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... marked the heavy market focus on the prospect of the White House imposing tariffs on imports from Mexico ...

Thank you for joining us for Eli ... Lilly's chair and CEO; Dr. Dan Skovronsky, chief scientific officer and president of Lilly Immunology; Lucas Montarce, chief financial officer; Anne White ...

Eli Lilly’s momentum stems from blockbuster GLP-1 therapies (Mounjaro, Zepbound), fuelling revenue growth, long-term margin expansion, and an ethos driving America’s health focus across ...

Eli Lilly said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide in 2025, a few months earlier than expected. The company expects to provide ...